Inhibitory effects of nontoxic protein volvatoxin A1 on pore-forming cardiotoxic protein volvatoxin A2 by interaction with amphipathic α-helix

FEBS Journal

Volumn 273, Issue 14, 2006, Pages 3160-3171

  Wu, Pei Tzu ^a   Lin, Su Chang ^b   Hsu, Chyong Ing ^a   Liaw, Yen Chywan ^b   Lin, Jung Yaw ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

Author keywords

Amphipathic helix; Co pull down experiment; Tandem repeat protein; Volvatoxin A1; Volvatoxin A2

Indexed keywords

COMPLEMENTARY DNA; DNA POLYMERASE; FLUORESCEIN ISOTHIOCYANATE; HEPARIN; LIPOSOME; TOXIN; UNCLASSIFIED DRUG; VOLVATOXIN A1; VOLVATOXIN A2;

ALPHA HELIX; AMINO ACID SEQUENCE; ARTICLE; BINDING SITE; CELL MEMBRANE; CHEMOTHERAPY; COMPLEX FORMATION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOTOXICITY; ERYTHROCYTE; HELA CELL; HEMOLYSIS; HUMAN; HUMAN CELL; MEMBRANE BINDING; MUSHROOM; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; TANDEM REPEAT; VOLVARIELLA VOLVACEA; X RAY CRYSTALLOGRAPHY;

AMINO ACID SEQUENCE; BASE SEQUENCE; BINDING SITES; BINDING, COMPETITIVE; CELL DEATH; CELL SURVIVAL; CONSERVED SEQUENCE; CRYSTALLOGRAPHY, X-RAY; DIMERIZATION; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, DRUG; ERYTHROCYTES; FUNGAL PROTEINS; GLUTATHIONE TRANSFERASE; HELA CELLS; HEMOLYSIS; HUMANS; HYDROPHOBICITY; LIPOSOMES; MOLECULAR SEQUENCE DATA; MYCOTOXINS; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RECOMBINANT PROTEINS; SEQUENCE HOMOLOGY, AMINO ACID;

BASIDIOMYCOTA; VOLVARIELLA VOLVACEA;

EID: 33745585798     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2006.05325.x     Document Type: Article

References (43)

1. Lin JY, Jeng TW, Chen CC, Shi GY & Tung TC (1973) Isolation of a new cardiotoxic protein from the edible mushroom, Volvariella volvacea. Nature 246, 524-525.
2. Fassold E, Slade AM, Lin JY & Nayler WG (1976) An effect of the cardiotoxic protein volvatoxin A on the function and structure of heart muscle cells. J Mol Cell Cardiol 8, 501-519.
3. Lin JY & Shi GY (1976) Toxicity of Volvatoxin A isolated from edible mushroom, Volvariella volvacea. J Taiwan Pharmaceut Assoc 28, 96-103.
4. Lin JY, Lin YJ, Chen CC, Wu HL, Shi GY & Jeng TW (1974) Cardiotoxic protein from edible mushrooms. Nature 252, 235-237.
5. Wu PT, Lin SC, Hsu CI & Lin JY (2004) Studies on structure and function of VVA1 isolated from Volvariella volvacea by site-directed mutagenesis. In Twelfth Symposium on Recent Advances in Cellular and Molecular Biology (Chung-Ming, Chang, eds), February 2-4, pp. 124. The Chinese Society of Cell and Molecular Biology, Taipei, Taiwan.
6. Weng YP, Lin YP, Hsu CI & Lin JY (2004) Functional domains of a pore-forming cardiotoxic protein, volvatoxin A2. J Biol Chem 279, 6805-6814.
7. Walker B, Krishnasastry M, Zorn L & Bayley H (1992) Assembly of the oligomeric membrane pore formed by Staphylococcal alpha-hemolysin examined by truncation mutagenesis. J Biol Chem 267, 21782-21786.
8. Hotze EM, Heuck AP, Czajkowsky DM, Shao Z, Johnson AE & Tweten RK (2002) Monomer-monomer interactions drive the prepore to pore conversion of a beta-barrel-forming cholesterol-dependent cytolysin. J Biol Chem 277, 11597-11605.
9. Czajkowsky DM, Hotze EM, Shao Z & Tweten RK (2004) Vertical collapse of a cytolysin prepore moves its transmembrane beta-hairpins to the membrane. EMBO J 23, 3206-3215.
10. Bayley H, Jayasinghe L & Wallace M (2005) Prepore for a breakthrough. Nat Struct Mol Biol 12, 385-386.
11. Valeva A, Palmer M & Bhakdi S (1997) Staphylococcal alpha-toxin: formation of the heptameric pore is partially cooperative and proceeds through multiple intermediate stages. Biochemistry 36, 13298-13304.
12. Song L, Hobaugh MR, Shustak C, Cheley S, Bayley H & Gouaux JE (1996) Structure of Staphylococcal alpha-hemolysin, a heptameric transmembrane pore. Science 274, 1859-1866.
13. Choe S, Bennett MJ, Fujii G, Curmi PM, Kantardjieff KA, Collier RJ & Eisenberg D (1992) The crystal structure of diphtheria toxin. Nature 357, 216-222.
14. Malovrh P, Viero G, Serra MD, Podlesek Z, Lakey JH, Macek P, Menestrina G & Anderluh G (2003) A novel mechanism of pore formation: membrane penetration by the N-terminal amphipathic region of equinatoxin. J Biol Chem 278, 22678-22685.
15. Milne JC, Furlong D, Hanna PC, Wall JS & Collier RJ (1994) Anthrax protective antigen forms oligomers during intoxication of mammalian cells. J Biol Chem 269, 20607-20612.
16. Benson EL, Huynh PD, Finkelstein A & Collier RJ (1998) Identification of residues lining the anthrax protective antigen channel. Biochemistry 37, 3941-3948.
17. Barth H, Aktories K, Popoff MR & Stiles BG (2004) Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins. Microbiol Mol Biol Rev 68, 373-402.
18. Montecucco C (2001) Detoxification of a bacterial toxin by the toxin itself. Trends Pharmacol Sci 22, 493-494.
19. Liu CL, Tsai CC, Lin SC, Wang LI, Hsu CI, Hwang MJ & Lin JY (2000) Primary structure and function analysis of the Abrus precatorius agglutinin A chain by site-directed mutagenesis. Pro(199) of amphiphilic alpha-helix H impairs protein synthesis inhibitory activity. J Biol Chem 275, 1897-1901.
20. Patel HV, Vyas AA, Vyas KA, Liu YS, Chiang CM, Chi LM & Wu W (1997) Heparin and heparan sulfate bind to snake cardiotoxin. Sulfated oligosaccharides as a potential target for cardiotoxin action. J Biol Chem 272, 1484-1492.
21. Vyas AA, Pan JJ, Patel HV, Vyas KA, Chiang CM, Sheu YC, Hwang JK & Wu W (1997) Analysis of binding of cobra cardiotoxins to heparin reveals a new beta-sheet heparin-binding structural motif. J Biol Chem 272, 9661-9670.
22. Gatineau E, Takechi M, Bouet F, Mansuelle P, Rochat H, Harvey AL, Montenay-Garestier T & Menez A (1990) Delineation of the functional site of a snake venom cardiotoxin: preparation, structure, and function of monoacetylated derivatives. Biochemistry 29, 6480-6489.
23. Venema RC, Sayegh HS, Arnal JF & Harrison DG (1995) Role of the enzyme calmodulin-binding domain in membrane association and phospholipid inhibition of endothelial nitric oxide synthase. J Biol Chem 270, 14705-14711.
24. Lin SC, Lo YC, Lin JY & Liaw YC (2004) Crystal structures and electron micrographs of fungal volvatoxin A2. J Mol Biol 343, 477-491.
25. Eisenberg D, Weiss RM & Terwilliger TC (1982) The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature 299, 371-374.
26. Hsu YT & Youle RJ (1997) Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem 272, 13829-13834.
27. Bhakdi S, Fussle R & Tranum-Jensen J (1981) Staphylococcal alpha-toxin: oligomerization of hydrophilic monomers to form amphiphilic hexamers induced through contact with deoxycholate detergent micelles. Proc Natl Acad Sci USA 78, 5475-5479.
28. Ole JB, James HG, Thorkild CB-H & Jesper BH (1982) Electroimmunochemical analysis of amphiphilic proteins and glycolipids stained with Sudan Black-containing detergent micelles. Electrophoresis 3, 89-98.
29. Tone B & Ole JB (1986) Electrophoretic migration velocity of amphiphilic proteins increases with decreasing Triton X-100 concentration: a new characteristic for their identification. Electrophoresis 7, 197-203.
30. Panchal RG, Cusack E, Cheley S & Bayley H (1996) Tumor protease-activated, pore-forming toxins from a combinatorial library. Nat Biotechnol 14, 852-856.
31. Liu S, Aaronson H, Mitola DJ, Leppla SH & Bugge TH (2003) Potent antitumor activity of a urokinase-activated engineered anthrax toxin. Proc Natl Acad Sci USA 100, 657-662.
32. Johannes L & Decaudin D (2005) Protein toxins: intracellular trafficking for targeted therapy. Gene Ther 12, 1360-1368.
33. Panchal RG, Smart ML, Bowser DN, Williams DA & Petrou S (2002) Pore-forming proteins and their application in biotechnology. Curr Pharm Biotechnol 3, 99-115.
34. Michl P & Gress TM (2004) Bacteria and bacterial toxins as therapeutic agents for solid tumors. Curr Cancer Drug Targets 4, 689-702.
35. Potrich C, Tomazzolli R, Dalla Serra M, Anderluh G, Malovrh P, Macek P, Menestrina G & Tejuca M (2005) Cytotoxic activity of a tumor protease-activated pore-forming toxin. Bioconjug Chem 16, 369-376.
36. Panchal RG (1998) Novel therapeutic strategies to selectively kill cancer cells. Biochem Pharmacol 55, 247-252.
37. Liu S, Bugge TH & Leppla SH (2001) Targeting of tumor cells by cell surface urokinase plasminogen activator-dependent anthrax toxin. J Biol Chem 276, 17976-17984.
38. Liu S, Redeye V, Kuremsky JG, Kuhnen M, Molinolo A, Bugge TH & Leppla SH (2005) Intermolecular complementation achieves high-specificity tumor targeting by anthrax toxin. Nat Biotechnol 23, 725-730.
39. Rono B, Romer J, Liu S, Bugge TH, Leppla SH & Kristjansen PE (2006) Antitumor efficacy of a urokinase activation-dependent anthrax toxin. Mol Cancer Ther 5, 89-96.
40. Kaku H, Tanaka Y, Tazaki K, Minami E, Mizuno H & Shibuya N (1996) Sialylated oligosaccharide-specific plant lectin from Japanese elderberry (Sambucus sieboldiana) bark tissue has a homologous structure to type II ribosome-inactivating proteins, ricin and abrin. cDNA cloning and molecular modeling study. J Biol Chem 271, 1480-1485.
41. Wu YH, Shih SF & Lin JY (2004) Ricin triggers apoptotic morphological changes through caspase-3 cleavage of BAT3. J Biol Chem 279, 19264-19275.
42. Shih SF, Wu YH, Hung CH, Yang HY & Lin JY (2001) Abrin triggers cell death by inactivating a thiol-specific antioxidant protein. J Biol Chem 276, 21870-21877.
43. Wilchek M, Miron T & Kohn J (1984) Affinity chromatography. Methods Enzymol 104, 3-55.